The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Translocation-related sarcomas.

På svenska

Author

  • Fredrik Mertens
  • Cristina R Antonescu
  • Peter Hohenberger
  • Marc Ladanyi
  • Piergiorgio Modena
  • Maurizio D'Incalci
  • Paolo G Casali
  • Massimo Aglietta
  • Thor Alvegård

Summary, in English

Sarcomas with chromosomal translocations represent only about one fourth of sarcoma diagnoses. However, like gastrointestinal stromal tumor (GIST), with its characteristic KIT or PDGFRA mutations, they are particularly interesting since they provide specific biological insights and mechanisms of action that may have an impact upon prognosis or therapy. These are mechanisms we are just beginning to exploit. In this section we will review the biology and clinical impact of translocation-associated sarcomas and review the clinical findings that have made a recent impact upon patients with these diverse diagnoses.

Publishing year

2009

Language

English

Pages

312-323

Publication/Series

Seminars in Oncology

Volume

36

Issue

4

Document type

Journal article

Publisher

W.B. Saunders

Topic

  • Cancer and Oncology
  • Medical Genetics

Status

Published

ISBN/ISSN/Other

  • ISSN: 0093-7754